Drugs associated with weight loss, such as Ozempic and Mounjaro, have taken the world by storm. While these treatments have done wonders for the pharmaceutical industry, they've also taken a toll on the food and beverage sector.One company that was hit the hard last year was Coca-Cola (KO 1.51%), a staple in Warren Buffett's portfolio. With more consumers tapping into health and wellness, anchored by the rising popularity of weight-loss medications, investor sentiment around Coca-Cola and it's sugary bevera ...